Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

Eli Lilly and Co's obesity drug Zepbound led to greater ... President Donald Trump’s announcement that he plans to sign an executive order aimed at slashing prescription drug prices in the US by 30% ...

The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

LONDON (Reuters) -U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United States, the company said on Wednesday.

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

President Donald Trump's executive order mandates drugmakers to lower prices to match those in affluent nations, threatening Roche's $50 billion U.S. investment plan. While the policy may be tough to ...

Eli Lilly's (NYSE: LLY) share price soared during the first Trump administration. That momentum continued with Joe Biden in the White House. However, it's a much different story so far in Trump's ...